DoW Multiple Sclerosis Clinical Trial Award deadline 2026
The current listed application deadline is August 12, 2026. Use this page to verify timing fast, then move into the full grant record for planning, comparison, and drafting.
Application Countdown
Use this page as the fast check for timing, then jump into the full grant record for filters, drafting, and comparison.
Quick facts
- Opportunity number
- Not listed
- Last updated
- May 5, 2026
- Expected awards
- 3
Deadline summary
Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. All applications must address at least one of the FY26 MSRP CTA focus areas. Clinical trials may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technol...